Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic

Patrick Gérardin, Vanina Guernier, Joëlle Perrau, Adrian Fianu, Karin Le Roux, Philippe Grivard, Alain Michault, Xavier de Lamballerie, Antoine Flahault, François Favier, Patrick Gérardin, Vanina Guernier, Joëlle Perrau, Adrian Fianu, Karin Le Roux, Philippe Grivard, Alain Michault, Xavier de Lamballerie, Antoine Flahault, François Favier

Abstract

Background: Chikungunya virus (CHIKV) caused a major two-wave seventeen-month-long outbreak in La Réunion Island in 2005-2006. The aim of this study was to refine clinical estimates provided by a regional surveillance-system using a two-stage serological assessment as gold standard.

Methods: Two serosurveys were implemented: first, a rapid survey using stored sera of pregnant women, in order to assess the attack rate at the epidemic upsurge (s1, February 2006; n = 888); second, a population-based survey among a random sample of the community, to assess the herd immunity in the post-epidemic era (s2, October 2006; n = 2442). Sera were screened for anti-CHIKV specific antibodies (IgM and IgG in s1, IgG only in s2) using enzyme-linked immunosorbent assays. Seroprevalence rates were compared to clinical estimates of attack rates.

Results: In s1, 18.2% of the pregnant women were tested positive for CHIKV specific antibodies (13.8% for both IgM and IgG, 4.3% for IgM, 0.1% for IgG only) which provided a congruent estimate with the 16.5% attack rate calculated from the surveillance-system. In s2, the seroprevalence in community was estimated to 38.2% (95% CI, 35.9 to 40.6%). Extrapolations of seroprevalence rates led to estimate, at 143,000 and at 300,000 (95% CI, 283,000 to 320,000), the number of people infected in s1 and in s2, respectively. In comparison, the surveillance-system estimated at 130,000 and 266,000 the number of people infected for the same periods.

Conclusion: A rapid serosurvey in pregnant women can be helpful to assess the attack rate when large seroprevalence studies cannot be done. On the other hand, a population-based serosurvey is useful to refine the estimate when clinical diagnosis underestimates it. Our findings give valuable insights to assess the herd immunity along the course of epidemics.

Figures

Figure 1
Figure 1
Map of La Réunion Island. The territory is divided into four regions: north bounded by orange and red lines, west bounded by orange, light green, dark green and red lines, south bounded by dark green and red lines, east by red lines. For each municipality, the ratio of laboratories which participated to the survey on pregnant woman and the related amount of the sera collected (n = x) are listed in parentheses.
Figure 2
Figure 2
Number of weekly incident cases of Chikungunya, La Réunion Island, March 28th, 2005 – April 16th, 2006 (n = 244,000). Reported by the active case-finding system between weeks 9 and 50, 2005 or estimated from the sentinel physician network between week 51 of 2005 and week 15, 2006. Published by Renault P, et al. in Am J Trop Med Hyg, 2007, 77: 727–731 [11], and reprinted with the kind permission of the American Society of Tropical Medicine and Hygiene (Atlanta, USA). "Survey 1" corresponds to the rapid serological survey on pregnant women (January 15th 2006 to February 15th 2006); "Survey 2" corresponds to the population-based SEROCHIK survey (August 17th to October 20th 2006).
Figure 3
Figure 3
Comparison of monthly suspected, self-reported and confirmed cases of Chikungunya in La Réunion Island between April 2005 and October 2006. The number of suspected cases recorded weekly by the CIRE (left scale) is compared to the number of cases identified in the population-based SEROCHIK survey (right scale). For the serosurvey, both self-reports (all subjects who have declared that they have been infected, without taking into account serology results) and confirmed self-reports (with a positive serology) are noted. We refer to the date of first clinical signs declared by the subjects during the survey conducted between August 17th 2006 and October 20th 2006. "Suspected cases" are defined as cases with a sudden onset of fever with temperature > 38.5°C and incapacitating arthralgia.

References

    1. Johnston RE, Peters CJ. Alphaviruses. In: Fields BN, Knipe DM, Howley PM, editor. Fields Virology. 3. Philadelphia: Lippincott-Raven; 1996. pp. 843–898.
    1. Laras K, Sukri NC, Larasati RP, Bangs MJ, Kosim R, Djauzi , Wandra T, Master J, Kosasih H, Hartati S, Beckett C, Sedyaningsih ER, Beecham HJ, 3rd, Corwin AL. Tracking the re-emergence of epidemic chikungunya virus in Indonesia. Trans R Soc Trop Med Hyg. 2005;99:128–141. doi: 10.1016/j.trstmh.2004.03.013.
    1. Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg (Lond) 1956;54:177–191.
    1. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Bréhin AC, Cubito N, Desprès P, Kunst F, Rey FA, Zeller H, Brisse S. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. Plos Med. 2006;3:e263. doi: 10.1371/journal.pmed.0030263.
    1. Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks – the globalization of vectorborne diseases. N Engl J Med. 2007;356:769–771. doi: 10.1056/NEJMp078013.
    1. Reiter P, Fontenille D, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis. 2006;6:463–464. doi: 10.1016/S1473-3099(06)70531-X.
    1. Perrau J, Catteau C, Michault A, Parain C, Favier F. Fin 300000 personnes avaient été atteintes par le Chikungunya. Economie de la Réunion. 2007;129:16–17.
    1. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, Wengling C, Michault A, Paganin F. Outbreak of chikungunya on reunion island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44:1401–1407. doi: 10.1086/517537.
    1. Staikowsky F, Le Roux K, Schuffenecker I, Laurent P, Grivard P, Develay A, Michault A. Retrospective survey of Chikungunya disease in Reunion Island hospital staff. Epidemiol Infect. 2008;136:196–206. doi: 10.1017/S0950268807008424.
    1. Paquet C, Quatresous I, Solet JL, Sissoko D, Renault P, Pierre V, Cordel H, Lassalle C, Thiria J, Zeller H, Schuffnecker I. Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006. Euro Surveill. 2006;11:E060202.3.
    1. Renault P, Solet J-L, Sissoko D, Balleydier E, Larrieu S, Filleul L, Lassalle C, Thiria J, Rachou E, De Valk H, Ilef D, Ledrans M, Quatresous I, Quenel P, Pierre V. A major epidemic of chikungunya virus infection in Reunion Island, France, 2005–2006. Am J Trop Med Hyg. 2007;77:727–731.
    1. Institut National de Veille Sanitaire Epidémie de Chikungunya à la Réunion/Océan Indien. Point au 17 février. 2006.
    1. Kish L. Survey sampling. Edited by Wiley and sons. New York; 1965. Some selection techniques; pp. 440–501.
    1. Institut National de Veille Sanitaire Epidémie de Chikungunya à la Réunion. Point de situation au 05 juillet 2006
    1. Grivard P, Le Roux K, Laurent P, Fianu A, Perrau J, Gigan J, Hoarau G, Grodin N, Staikowsky F, Favier F, Michault Al. Molecular and serological diagnosis of chikungunya virus infection. Pathol Biol (Paris) 2007 Oct 4.
    1. Gérardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, Touret Y, Lenglet Y, Bouveret A, Grivard P, Le Roux K, Blanc S, Schuffenecker I, Couderc T, Arenzana-Seisdedos F, Lecuit M, Robillard PY. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. Plos Med. 2008;5:e60. doi: 10.1371/journal.pmed.0050060. doi:10;1371/journal.pmed.0050060.
    1. Sissoko D, Malvy D, Giry C, Delmas G, Paquet C, Gabrie P, Pettineli F, Sanquer MA, Pierre V. Outbreak of chikungunya fever in Mayotte, Comoros archipelago, 2005–2006. Trans R Soc Trop Med Hyg. 2008 Apr 7.
    1. Institut National de Veille Sanitaire Epidémie de chikungunya à la Réunion. Point de situation au 16 février 2006
    1. Institut National de Veille Sanitaire Epidémie de chikungunya à la Réunion. Point de situation au 23 février 2006
    1. Ministère de la Santé et des Solidarités, Ministère de l'Outre Mer, Ministère délégué au tourisme Plan global de lutte contre le chikunungya
    1. Direction Régionale des Affaires Sanitaires et Sociales de la Réunion (DRASS) et Cellule interrégionale d'épidémiologie (CIRE) Réunion-Mayotte Zoonoses. Chikungunya. Conseil aux voyageurs et réponses aux questions les plus fréquentes.
    1. Blackburn N, Schoub B, O'Connell K. Reliability of the clinical surveillance criteria for measles diagnosis [letter] Bull World Health Organ. 2000;78:861.
    1. Kles V, Michault A, Rodhain F, Mevel F, Chastel C. Enquêtes sérologiques concernant les arboviroses à Flaviridae sur l'île de la Réunion (1971–1989) Bull Soc Pathol Exot. 1994;87:71–76.
    1. Thaikruea L, Chareansook O, Reanphumkamrit S, Dissomboon P, Phonian R, Ratchud S, Kounsang Y, Buranapiyawong D. Chikungunya in Thailand: a re-emerging disease? 1997;28:359–364.
    1. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng, Thailand. Am J Epidemiol. 2002;156:40–51. doi: 10.1093/aje/kwf005.
    1. Méndez F, Barreto M, Arias JF, Rengifo G, Munoz J, Burbano ME, Parra B. Human and mosquito infections by dengue viruses during and after epidemics in a dengue-epidemic region of Colombia. Am J Trop Med Hyg. 2006;74:678–683.
    1. Biggerstaff BJ, Peterson LR. Estimated risk of West Nile Virus transmission through blood transfusion in the US, 2002. Transfusion. 2003;43:1007–1017. doi: 10.1046/j.1537-2995.2003.00480.x.
    1. CDC Information and guidance for clinicians – West Nile virus: clinical description, 2004
    1. Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, Bedno S, Burke H, Dumila AM, Konde J, Njenga MK, Sang R, Breiman RF. Seroprevalence of chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg. 2008;78:333–337.
    1. Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, Allaranger Y, Ball MD, Powers AM, Ofula V, Onyango C, Konongoi LS, Sang R, Njenga MK, Breiman RF. Seroprevalence of chikungunya virus infection on Grande Comore Island, Union of the Comoros, 2005. Am J Trop Med Hyg. 2007;76:1189–1193.
    1. Pialoux G, Gaüzere BA, Jaureguiberry S, Strobel S. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:319–327. doi: 10.1016/S1473-3099(07)70107-X.
    1. Boëlle PY, Thomas G, Vergu E, Renault P, Valleron AJ, Flahault A. Investigating transmission in a two-wave epidemic of chikungunya fever, Réunion Island. Vector Borne Zoonotic Dis. 2008;8:207–218. doi: 10.1089/vbz.2006.0620.
    1. Dumont Y, Chiroleu F, Domerq C. On a temporal model for the chikungunya disease: Modeling, theory and numerics. Math Biosci. 2008;213:80–91. doi: 10.1016/j.mbs.2008.02.008.

Source: PubMed

3
S'abonner